We are live on !
Find out more
Prostatis Group Portfolio holdings
AUM
$429M
Turnover
26.7%
1-Year Est. Return
26.55%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+26.55%
3 Year Est. Return
+72.92%
5 Year Est. Return
+90.2%
10 Year Est. Return
–
AUM
$164M
AUM Growth
+$77.1M
(+89%)
Cap. Flow
+$70.8M
Cap. Flow % of AUM
Cap. Flow %
43.21%
Top 10 Holdings %
Top 10 Hldgs %
45.49%
Holding
112
New
48
Increased
28
Reduced
19
Closed
15
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Value ETF
VTV
|
+$16.6M |
| 2 |
ProShares Short S&P500
SH
|
+$9.7M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$6.7M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$6.45M |
| 5 |
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 GARP ETF
SPGP
|
+$5.24M |
| 2 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$4.01M |
| 3 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$3.52M |
| 4 |
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
|
+$2.79M |
| 5 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$2.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.43% |
| 2 | Healthcare | 3.63% |
| 3 | Technology | 2.33% |
| 4 | Industrials | 1.89% |
| 5 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard Morningstar Value ETF
VTV
$194B
| $16.9M | 10.3% |
+120,222
| New | +$16.6M |
2022 Q4
0 quarters
|
|
2
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.96B
| $11M | 6.72% |
307,253
+9,991
| +3% | +$352K |
2021 Q1
7 quarters
|
|
|
3
ProShares Short S&P500
SH
$961M
| $9.7M | 5.92% |
+151,226
| New | +$9.7M |
2022 Q4
0 quarters
|
|
|
4
Vanguard Total International Stock ETF
VXUS
$158B
| $6.93M | 4.23% |
+133,927
| New | +$6.7M |
2022 Q4
0 quarters
|
|
|
5
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $6.46M | 3.94% |
+126,692
| New | +$6.45M |
2022 Q4
0 quarters
|
|
6
Vanguard Intermediate-Term Bond ETF
BIV
$28.5B
| $5.41M | 3.3% |
72,852
-1,529
| -2% | -$113K |
2022 Q3
1 quarter
|
|
|
7
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$208M
| $4.75M | 2.9% |
+159,719
| New | +$4.65M |
2022 Q4
0 quarters
|
|
|
8
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$188M
| $4.61M | 2.81% |
131,046
-75,857
| -37% | -$2.65M |
2022 Q3
1 quarter
|
|
9
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
| $4.41M | 2.69% |
+51,995
| New | +$4.44M |
2022 Q4
0 quarters
|
|
10
iShares ESG Optimized MSCI USA ETF
SUSA
$4.03B
| $4.4M | 2.68% |
+53,434
| New | +$4.4M |
2022 Q4
0 quarters
|
|
11
iShares MSCI KLD 400 Social ETF
DSI
$5.34B
| $4.39M | 2.68% |
+61,113
| New | +$4.39M |
2022 Q4
0 quarters
|
|
12
Vanguard Morningstar Small-Cap ETF
VB
$79.1B
| $3.99M | 2.43% |
+21,727
| New | +$4.03M |
2022 Q4
0 quarters
|
|
13
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $3.59M | 2.19% |
47,656
-2,076
| -4% | -$156K |
2020 Q4
8 quarters
|
|
14
State Street Health Care Select Sector SPDR ETF
XLV
$48.4B
| $2.8M | 1.71% |
20,590
+18,668
| +971% | +$2.47M |
2022 Q1
3 quarters
|
|
15
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $2.78M | 1.7% |
+73,452
| New | +$2.71M |
2022 Q4
0 quarters
|
|
16
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $2.6M | 1.59% |
+34,866
| New | +$2.54M |
2022 Q4
0 quarters
|
|
17
First Trust Enhanced Short Maturity ETF
FTSM
$6.8B
| $2.59M | 1.58% |
43,571
+10,093
| +30% | +$600K |
2022 Q2
2 quarters
|
|
18
State Street Financial Select Sector SPDR ETF
XLF
$53.3B
| $2.58M | 1.57% |
+75,354
| New | +$2.55M |
2022 Q4
0 quarters
|
|
19
State Street Industrial Select Sector SPDR ETF
XLI
$31.7B
| $2.49M | 1.52% |
+25,325
| New | +$2.41M |
2022 Q4
0 quarters
|
|
20
State Street Utilities Select Sector SPDR ETF
XLU
$24.3B
| $2.44M | 1.49% |
+69,176
| New | +$2.35M |
2022 Q4
0 quarters
|
|
21
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.24B
| $2.39M | 1.46% |
+64,606
| New | +$2.38M |
2022 Q4
0 quarters
|
|
22
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.8B
| $2.36M | 1.44% |
+35,907
| New | +$2.25M |
2022 Q4
0 quarters
|
|
23
State Street Materials Select Sector SPDR ETF
XLB
$8.31B
| $2.34M | 1.43% |
+60,260
| New | +$2.31M |
2022 Q4
0 quarters
|
|
24
Vanguard Total International Bond ETF
BNDX
$83.8B
| $2.07M | 1.26% |
43,565
+9,223
| +27% | +$444K |
2022 Q3
1 quarter
|
|
25
iShares ESG Aware MSCI EM ETF
ESGE
$6.26B
| $1.98M | 1.21% |
+65,848
| New | +$1.93M |
2022 Q4
0 quarters
|
|
Similar funds
PA
CWM
Prostatis Group's Q4 2022 Portfolio in Review
As of Q4 2022, Prostatis Group held 112 positions worth $164M, up 89% from $86.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prostatis Group deployed $70.8M of net new capital in Q4 2022, opening 48 new positions and adding to 28 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 120,222 shares worth $16.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 77% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Invesco S&P 500 GARP ETF, an estimated $5.24M trimmed.
- Prostatis Group's largest Q4 2022 buy was Vanguard Morningstar Value ETF: 120,222 shares worth $16.9M.
- Prostatis Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2022, an estimated $2.47M increase.
- Prostatis Group's biggest Q4 2022 reduction was Invesco S&P 500 GARP ETF, cutting an estimated $5.24M.
- Prostatis Group fully exited Invesco S&P MidCap Momentum ETF in Q4 2022, selling an estimated $4.01M.
- Prostatis Group's ten largest holdings make up 45% of its $164M portfolio in Q4 2022.
- Prostatis Group opened 48 new positions and closed 15 in Q4 2022.
- Prostatis Group's portfolio value rose 89% quarter-over-quarter to $164M.
Based on Prostatis Group's 13F filing for Q4 2022, filed 23 Mar 2023.